Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain and stress control during peripheral venous cannulation in children
IRCT20151003024317N8Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of midazolam and ketamine in anxiety disorder (4 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Pulse rate, Respiratory rate and 2 more. Started Oct 2019; status: completed.
02
Drugs
midazolamketamine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20151003024317N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151003024317N8.